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Abstract
Background: B cells play a role in pregnancy due to their humoral and regulatory activities. To our knowledge,
different maturational stages (from transitional to memory) of circulating B cell subsets have not yet been
characterized (cell quantification and phenotype identification) in healthy pregnant women. Thus, the objective of
our study was to characterize these subsets (as well as regulatory B cells) from late pregnancy to post-partum and
to compare them with the circulating B cells of non-pregnant women.
Methods: In all of the enrolled women, flow cytometry was used to characterize the circulating B cell subsets
according to the expression of IgD and CD38 (Bm1-Bm5 classification system). Regulatory B cells were characterized
based on the expression of surface antigens (CD24, CD27, and CD38) and the production of IL-10 after lipopolysaccharide
stimulation.
Results: Compared to the absolute counts of B cells in the non-pregnant women (n= 35), those in the pregnant women
(n = 43) were significantly lower (p < 0.05) during the 3rd trimester of pregnancy and on delivery day (immediately after
delivery). The percentages of these cells on delivery day and at post-partum were significantly lower than those in the
non-pregnant women.
In general, the absolute counts and percentages of the majority of the B cell subsets were significantly lower in the 3rd
trimester of pregnancy and on delivery day than in the non-pregnant women. However, these counts and percentages
did not differ significantly between the post-partum and the non-pregnant women.
The most notable exceptions to the above were the percentages of naïve B cells (which were significantly higher in the
3rd trimester and on delivery day than in the non-pregnant women) and of CD24hiCD38hi regulatory B cells (which were
significantly higher in the post-partum than in the non-pregnant women).
Conclusion: According to our study, the peripheral B cell compartment undergoes quantitative changes during normal
late pregnancy and post-partum. Such findings may allow us to better understand immunomodulation during human
pregnancy and provide evidence that could aid in the development of new strategies to diagnose and treat
pregnancy-associated disturbances. Our findings could also be useful for studies of the mechanisms of maternal
responses to vaccination and infection.
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Background
The immune system of pregnant women tolerates a
genetically foreign fetus. This physiological adaptation is
thought to be promoted by an array of anti-inflammatory
and pro-inflammatory cytokines that are produced by T
and B cells [1]. This state of immunological tolerance may
influence the course of pre-existing pathologies (e.g., auto-
immune diseases) [2] and may also increase fetal-maternal
susceptibility to infection [3]. Furthermore, a decrease of
function of B cells with loss of responsiveness to mitogens
and infectious agents during the course of normal human
pregnancy has also been reported [4].
B cells have a role in pregnancy because of their humoral
activity (i.e., the production of protective antibodies against
paternal antigens during pregnancy and the production of
auto-antibodies that may lead to pregnancy complications)
[5]. Normally, B cells leave the bone marrow and enter the
circulation as immature transitional B cells, which later ma-
ture into naïve B cells. Finally, when naïve B cells encounter
their cognate antigens in secondary lymphoid organs, these
cells become activated and mature into memory B cells and
plasma cells [6, 7]. B cell subsets of different maturational
stages, from transitional to memory B cells, have been iden-
tified in peripheral blood using the mature B (Bm)1-Bm5
classification system. This classification system has proven
to be effective in the identification of disturbances in the
proportions of peripheral blood B cell subsets in patients
with autoimmune diseases (e.g., Lupus or Sjögren’s syn-
drome) [8–10] and in those undergoing therapy (e.g., with
biological agents), by assessing the depletion and repopula-
tion of B cells [11].
Furthermore, it has been suggested that, in addition to
their humoral activity, specific B cells can also have a
regulatory function although this is still controversial.
According to recent studies, regulatory B cells (Bregs)
can inhibit pro-inflammatory responses by secreting the
anti-inflammatory cytokine IL-10 [12, 13]. Breg counts
increase in the first trimester of pregnancy, suppressing
unwanted immune responses of maternal effector T cells,
protecting against pregnancy loss [14]. While the pheno-
type and function of regulatory T cells has been extensively
studied [15], further studies are needed to investigate the
mechanisms behind the activation and expansion of Bregs
and other B cell subsets in pregnancy.
These regulatory functions have been attributed to dif-
ferent B cell subsets, and despite some controversy, great
progress has been made in the characterization of Bregs.
The inability to identify a Breg-specific transcription fac-
tor, together with the phenotypic heterogeneity of Bregs,
supports the idea that Bregs are not lineage specific and
that they may expand in response to inflammation when
immunosuppression is necessary [16]. It remains unclear
whether the regulatory B cell function is a specific role
of a particular subset or whether it is a reflection of their
maturation stage. Although the expression of IL-10 has
been a valuable tool in defining populations of Bregs,
CD24hiCD27+ and CD24hiCD38hi are the most frequently
characterized phenotypes in humans [9, 12, 13].
Several studies [17–27] both prospective and cross-
sectional have reported on circulating B cells during
normal human pregnancy with majority describing lower
total numbers and/or frequency when compared to levels
post-partum or in healthy non-pregnant. Most studies
[17, 19–24, 27] have only investigated total B cells as
defined by the expression of CD20 or CD19 with older
studies [18, 25, 26] using either expression of Ia (HLA-DR)
or surface immunoglobulin. A few studies [17, 19, 24, 27]
have reported on the frequency of B cell subsets expressing
CD5 with majority describing lower frequency or lower
total numbers of this subset during pregnancy, at delivery
or early in the postpartum period. One study [19] reported
lower CD21 and CD23 frequencies at delivery. However,
peripheral B cells have not been characterized in human
pregnancy while considering the different maturational
stages, from transitional to memory B cells (using CD38
and immunoglobulin IgD as differentiation markers). Con-
sequently, the objective of our study was to characterize
these specific peripheral blood B cell subsets (transitional,
naïve, unswitched memory, post-germinal, and resting
memory B cells as well as plasmablasts) and Bregs
(CD24hiCD27+, CD24hiCD38hi and IL-10 regulatory B
cells) from late pregnancy to post-partum and compare
them with those in non-pregnant women.
Methods
Study population
This prospective observational study followed healthy
pregnant women over time to characterize (i.e., cell quanti-
fication and phenotype identification) their peripheral blood
B cell subsets from late pregnancy to post-partum. This
characterization of B cells in the pregnant women was also
compared with the characterization of single samples of
peripheral blood B cells from a control group of healthy
non-pregnant women to investigate changes associated
with pregnancy.
Sequential non-laboring healthy women with singleton
pregnancies who were attending an outpatient clinic
(routine obstetrical care) during the 3rd trimester were
recruited for participation. None of the pregnancies had
complications prior to recruitment. Furthermore, all of
the fetuses exhibited appropriate growth (as measured
by uterine fundal height and by ultrasound performed
after 28 weeks of gestation).
Sequential non-pregnant women who were attending an
outpatient clinic were also recruited (healthy controls).
These were asymptomatic women who were attending
their annual routine well-woman exams.
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For all of the women, the exclusion criteria were a his-
tory of diabetes, hypertension, or autoimmune disease
and smoking during the 6 months prior to peripheral
blood sample collection. Additional exclusion criteria for
the pregnant women included prenatal use of any medi-
cation (other than vitamins and iron supplements) and
ongoing complications in the pregnancy. Non-pregnant
women taking oral contraceptives were also excluded, as
these drugs affect circulating B cells [28].
All of the women were recruited at the Hospital CUF
Descobertas in Lisbon (Portugal) between July 2013 and
March 2014. The Ethics Committee of this hospital ap-
proved the study protocol. All of the recruited women
provided written informed consent before the start of
the study.
Study visit procedures
Three visits were planned for the pregnant women: visit
1 was planned for the 3rd trimester of pregnancy (3rd
trimester); visit 2, for the day of delivery; and visit 3, for
post-partum (at least 6 weeks after delivery). A single
visit was planned for the non-pregnant controls.
To characterize B cell subsets from late pregnancy to
post-partum, peripheral blood samples were collected from
all of the pregnant women at each planned visit: the “3rd
trimester” sample was collected at visit 1, the “on delivery
day” sample was collected at visit 2 (immediately after de-
livery, within 15 min after placental expulsion and oxytocin
administration), and the “post-partum” sample was col-
lected at visit 3. A peripheral blood sample was collected
from the non-pregnant women at the planned visit, which
took place during the follicular phase of their menstrual
cycle because hormone status during the luteal phase is
similar to that during pregnancy [29].
The baseline data collected for all women at the time
of enrollment included demographics (age and ethnicity),
anthropometrics [body mass index (BMI)], obstetric his-
tory, and systolic and diastolic blood pressures. The data
collected for the pregnant women on the day of delivery in-
cluded gestational age, type of analgesia and/or anesthesia,
and mode of delivery. The data collected for the newborns
included gender, weight, and 1-min and 5-min Apgar
scores.
Flow cytometry analysis and laboratory measurements
Peripheral blood samples were collected into EDTA-coated
and heparinized tubes. These samples were analyzed by
four-color flow cytometry (BD FACSCalibur, BD Biosci-
ences, San Jose, CA, USA) to characterize B cell subsets
and their maturation profiles. MultisetTM and CellQuest
3.3TM (BD Biosciences) software were used for both acqui-
sition and analysis.
To obtain absolute counts of B cells (CD19+), a single-
platform strategy was used. EDTA samples were assayed
using a lyse-no-wash technique, with a BD IMK Kit with
BD Trucount™ Tubes (BD Biosciences). The assay was
performed according to the manufacturer’s instructions.
In brief, 50 μL of blood were incubated for 15 min in
the dark, at room temperature, with the monoclonal
antibodies provided in the kit, in Trucount™ tubes con-
taining a calibrated number of microbeads for counting
purposes. Red blood cells were then lysed with the lysing
solution (also provided with the BD IMK Kit), for
15 min and finally samples were acquired. The cells were
gated on CD45/SSC, and a minimum of 2500 lympho-
cyte events were acquired. Multiset software provided
percentage and absolute counts of B cells using the
number of microbeads in each Trucount™ tube, along
with the number of microbead and lymphocyte events
acquired in each tube.
To study the surface B cell markers, a modified lyse-wash
protocol was used. EDTA samples were washed twice in
phosphate-buffered saline (PBS) to lower background stain-
ing. The washed cells were then stained with a panel of
monoclonal antibodies (mAbs) that were conjugated with
different fluorochromes: anti-CD19 PerCPCy5.5 (clone
HIB19, Biolegend), anti-CD24 PE (clone ML5, Biolegend),
anti-CD27 FITC (clone O323, Biolegend), CD38 APC
(clone HIT2, Biolegend), and anti-IgD PE (clone IA6-2, BD
Pharmingen). Red blood cells were incubated for 15 min at
room temperature in the dark. The red cells were then
lysed with BD FACS lysing solution (BD Biosciences)
according to the manufacturer’s instructions. After a
wash step with PBS, events were acquired. For the
characterization of IL-10-producing Bregs, heparin sam-
ples were incubated for 5 h at 37 °C in a 5 % CO2 atmos-
phere with phorbol 12-myristate 13-acetate (PMA)
(50 ng/mL, Sigma Aldrich), calcium ionophore (1 μg/mL,
Sigma Aldrich), and lipopolysaccharide (LPS) (10 μg/mL,
Sigma Aldrich) in the presence of Brefeldin A (1.0 μg/ml,
BD Pharmingen) [13, 30]. After the stimulation, the red
blood cells were lysed via the addition of BD FACS lysing
solution and were stained for surface markers with anti-
CD3 FITC (clone SK7, BD Biosciences), anti-CD19
PerCPCy5.5 (clone HIB19, Biolegend), and anti-CD8 APC
(clone SK1, Biolegend) mAbs. The Cytofix-Cytoperm
kit (BD Pharmingen) was used for cell fixation and
permeabilization according to the manufacturer’s instruc-
tions. To assess the cytoplasmic expression of IL-10 in the
B cells, a final intracellular staining step with an anti-IL-10
PE mAb (clone JES3-19F1, Biolegend) was performed be-
fore cell acquisition. A minimum of 2000 B cells (CD19+)
were acquired in all tubes (gate in CD19/SSC). The analysis
strategies are presented in Figs. 1 and 2. The flow cytometry
results are presented as a percentage of total B cells
and as absolute cell counts (cells/μL).
The Bm1-5 classification system used to identify the de-
velopment of mature B cells was based on the expression
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of IgD/CD38 phenotypic markers. The cells were charac-
terized as follows: transitional B cells (Bm2’: IgD+CD38hi),
naïve B cells (Bm2: IgD+CD38+), unswitched memory B
cells (Bm1: IgD+CD38−), and switched memory B cells
(Bm5: IgD−CD38+/−) and were subsequently divided into
post-germinal memory B cells (early Bm5: IgD−CD38+),
resting memory (late Bm5: IgD−CD38−) B cells, and
plasmablasts (Bm3 + Bm4: IgD−CD38hi) [8–10, 14].
Bregs were evaluated in three different populations:
CD24hiCD27+, CD24hiCD38hi and IL-10-producing B cells.
Our laboratory measurement included both absolute
counts and percentages of total B cells and the different
B cell subsets, as we feel that the two types of data are
complementary. Percentages were measured as these allow
interpreting the relative fluctuations in distinct B cell sub-
sets from pregnancy to post-partum. Absolute counts were
also measured and reported, although we are aware that
pregnancy is characterized by variable degrees of hemodilu-
tion, and that changes in these counts may not reflect true
variations in the total numbers of circulating cells.
Fig. 1 Identification of B cell subsets according to Bm1-5 classification system. a and b Gating strategy for CD19+ B cells using an initial CD19/SSC plot
and refinement of the gate using a plot of FSC vs SSC. c Bm1-5 classification from double staining for IgD and CD38 (unswitched memory
Bm1: IgD+CD38−; naïve Bm2: IgD+CD38+; transitional Bm2′: IgD+CD38hi; plasmablasts Bm3 + Bm4: IgD−CD38hi; post-germinal memory/early
eBm5: IgD−CD38+; and resting memory/late Bm5: IgD−CD38−)
Fig. 2 Identification of regulatory B cell subsets. a and b Gating strategy for CD24hiCD27+ (a) and CD24hiCD38hi (b) Bregs; c and d IL-10-producing
CD19+ B cells (CD19+ B cells were analyzed for the expression of IL-10 after a 5-h incubation period without stimulation (c) and with stimulation (d)
with phorbol 12-myristate 13-acetate, calcium ionophore and lipopolysaccharide)
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Statistical analysis
If the baseline data were normally distributed, they were
presented as means (±standard deviations); otherwise,
these data were presented as medians and ranges. Cat-
egorical variables were described as absolute and relative
frequencies and were expressed as percentages.
Cell counts and percentages were presented as me-
dians and ranges. If normally distributed, 2 independent
groups were compared using Student’s t-tests; otherwise,
Mann–Whitney U tests were used. If normally distrib-
uted, pairs of samples were compared using paired
Student’s t-tests; otherwise, Wilcoxon signed-rank tests
were used. For normally distributed data, comparisons
between more than 2 groups were performed using
ANOVA I; otherwise, Kruskal-Wallis tests were used.
Statistical significance was defined by a P-value <0.05.
The P-values for the comparisons of B cells between
the non-pregnant women and pregnant women at differ-
ent visits, as well as for the comparisons of the B cells of
the pregnant women between visits, were adjusted for
multiplicity using the Benjamini and Yekutieli method
[31]. All of the data were analyzed using R software, ver-
sion 3.12 for Windows.
Results
Baseline characteristics
A total of 78 women were enrolled in the study (43 preg-
nant and 35 non-pregnant). The characteristics of these
women and of their newborns are presented in Table 1.
The mean BMI of the non-pregnant women was 21.5
(±2.8) Kg/m2, while for the pregnant, it was 26.2 (±2.8)
Kg/m2. All of the women were normotensive [mean sys-
tolic blood pressure for the non-pregnant was 119.8
(±10.5) mmHg, while for the pregnant, it was 115.7 (±9.3)
mmHg; mean diastolic blood pressure for the non-
pregnant was 74.7 (±7.4) mmHg, while for the pregnant, it
was 67.4 (±7.4) mmHg]. Among the non-pregnant women,
the median number of weeks since the last pregnancy
(regardless of whether the pregnancies were interrupted
or resulted in a live birth) was 169 (23–449). The me-
dian gestational age in the 3rd trimester of pregnancy
was 33.0 (31–35) weeks, while it was 39.0 (37–41)
weeks on the day of delivery. The pregnant group was
significantly younger (p = 0.016) and included signifi-
cantly more nulliparous women (p < 0.001) than the
non-pregnant group. All of the pregnant women, regard-
less of the mode of delivery, received regional analgesia
and/or anesthesia. No general anesthesia was administered
to these women. All of the pregnant women were dis-
charged from the hospital 2 days after a vaginal delivery or
3 days after a cesarean section. Final post-partum mea-
surements were carried out a median of 45 (41–58) days
after delivery.
Characterization of the B cell population (CD19+)
The characterization of the B cell population for all of
the enrolled women is presented in Fig. 3. The median
absolute numbers (259 [110–485]) and percentages (12
[6–20]) of these cells in the non-pregnant were within
the expected normal ranges of our protocol (absolute
count: 80–616 cells/μL; percentage: 5–22 %). The abso-
lute counts of B cells at delivery were significantly lower
(p < 0.05) than those at post-partum and in the non-
pregnant women. Furthermore, the absolute counts of
these cells during the 3rd trimester were also significantly
lower (p < 0.05) than those in the non-pregnant. The
percentages of B cells at delivery and at post-partum
were significantly lower than those in the pregnant
women during the 3rd trimester of pregnancy and in
the non-pregnant.
Table 1 Characteristics of the women enrolled in the study and
of their newborns
Non-pregnant women
(n = 35)
Pregnant women
(n = 43)
Age in years, median (range) 35.0 (20–40) 32.0 (25–41)*
Ethnicity, n (%)
White 35 (100) 42 (97.8)
Black 0 1 (2.2)
Gestational age in weeks, median (range)
3rd trimester 33.0 (31–35)
Day of delivery 39.0 (37–41)
Parity, n (%)
Nulliparous 5 (14.3) 24 (55.8)*
Primiparous 14 (40) 18 (41.9)
Multiparous 16 (45.7) 1 (2.3)
Mode of delivery, n (%)
Vaginal 18 (41.8)
Cesarean 25 (58.2)
Elective cesareana 14 (55.6)
Intrapartum cesareanb 11 (44.4)
Newborns
Birth weight in grams,
mean (± SD)
3265.0 (±393.5)
Gender, n (%)
Male 22 (51)
Female 21 (49)
APGAR score, median (range)
1-min Apgar score 9 (6; 10)
5-min Apgar score 10 (9; 10)
5-min Apgar score less
than 7
0 (0)
Note: SD standard deviation; apreformed prelabor; bperformed in labor;
*statistically significant differences (p< 0.05) between pregnant and non-pregnant
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Characterization of maturational stages of B cells
The characterization of specific B cell subsets (transi-
tional, naïve, unswitched memory, post-germinal, and
resting memory B cells as well as plasmablasts) for all of
the enrolled women is presented in Fig. 4 (absolute
counts) and Fig. 5 (percentages). The absolute counts of
transitional B cells, unswitched memory B cells, resting
memory B cells, and plasmablasts during the 3rd trimes-
ter of pregnancy and on delivery day were significantly
lower (p < 0.05) than the corresponding counts in the
non-pregnant. The absolute counts of naïve and of post-
germinal memory/early B cells did not significantly differ
(p ≥ 0.05) between the pregnant and non-pregnant
women at any of the study visits. The absolute counts of
all of the B cell subsets, excluding naïve B cells, were
significantly higher (p < 0.05) at post-partum compared
to those during the 3rd trimester of pregnancy and on
delivery day.
The percentages of transitional B cells in the 3rd trimes-
ter of pregnancy and on delivery day were significantly
lower (p < 0.05) than those in the non-pregnant and post-
partum women. Conversely, the percentages of naïve B
cells in the 3rd trimester of pregnancy and on delivery day
were significantly higher (p < 0.05) compared those in both
the non-pregnant and post-partum women. No significant
differences (p < 0.05) in the percentages of unswitched
memory, post-germinal memory, and resting memory B
cells as well as of plasmablasts were identified between the
pregnant and non-pregnant women at any of the study
visits. However, the percentages of unswitched memory
and resting memory B cells and plasmablasts were signifi-
cantly lower (p < 0.05) during the 3rd trimester compared
to post-partum. Furthermore, the percentages of plasma-
blasts were also significantly lower (p < 0.05) on delivery
day compared to post-partum.
Characterization of Breg
The characterization of Breg is presented in Fig. 6.
The absolute counts of IL-10 regulatory B cells and
CD24hiCD38hi Bregs during the 3rd trimester of pregnancy
and on delivery day were significantly lower (p < 0.05) than
those in the post-partum women. Additionally, the absolute
counts of CD24hiCD38hi Bregs were also significantly lower
(p < 0.05) during the 3rd trimester of pregnancy and on de-
livery day compared to the corresponding counts in the
non-pregnant women. The absolute counts of CD24hiCD27+
Fig. 3 B cell population in peripheral blood samples. Delivery, within 15 min after placental expulsion; Post-partum, at least 6 weeks after delivery;
The bottom line represents the 25th percentile, the top line represents the 75th percentile, and the middle line represents the median. * p < 0.05;
** p < 0.001
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Fig. 4 Maturational stages of B cells (absolute counts) in peripheral blood samples according to Bm1-5 classification. Bm1-5 classification, IgD/CD38 cell
surface markers; Delivery, within 15 min after placental expulsion; Post-partum, at least 6 weeks after delivery; Non-pregnant women. The bottom line
represents the 25th percentile, the top line represents the 75th percentile, and the middle line represents the median. * p < 0.05; ** p < 0.001
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Fig. 5 Maturational stages of B cells (percentages) in peripheral blood samples according to Bm1-5 classification. Bm1-5 classification, IgD/CD38
cell surface markers; Delivery, within 15 min after placental expulsion; Post-partum, at least 6 weeks after delivery; Non-pregnant women. The bottom
line represents the 25th percentile, the top line represents the 75th percentile, and the middle line represents the median. * p < 0.05; ** p < 0.001
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Fig. 6 Regulatory B cells in peripheral blood samples (absolute counts and percentages). Delivery, within 15 min after placental expulsion;
Post-partum, at least 6 weeks after delivery; Non-pregnant women. The bottom line represents the 25th percentile, the top line represents the
75th percentile, and the middle line represents the median. * p < 0.05; ** p < 0.001
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Bregs did not significantly differ between the pregnant
and non-pregnant women or between study visits.
The percentages of CD24hiCD38hi Bregs during the
3rd trimester of pregnancy and on delivery day were signifi-
cantly lower (p < 0.05) than those in the non-pregnant and
post-partum women. Furthermore, the percentages of these
cells at post-partum were significantly higher (p < 0.05) than
those in the non-pregnant women. The percentages of IL-
10 regulatory B cells and of CD24hiCD27+ Bregs did not
significantly differ between the pregnant and non-pregnant
women or between study visits.
Discussion
According to our study, late-stage pregnancy (between
the 3rd trimester and delivery) is associated with periph-
eral blood B cell lymphopenia. Indeed, the absolute
counts and percentages of most B cell subsets in the 3rd
trimester of pregnancy and on delivery day were signifi-
cantly lower compared to the corresponding counts and
percentages in the non-pregnant. However, these differ-
ences did not significantly differ between the post-partum
and non-pregnant women, suggesting that at this later
time point, the absolute counts and percentages of most B
cell subsets revert (or at least partially revert) to normal
values. The most notable exceptions to this observation
were identified for naïve B cells (whose percentages were
significantly higher during the 3rd trimester and on deliv-
ery day than in the non-pregnant) and for CD24hiCD38hi
Bregs (whose percentages were significantly higher in the
post-partum compared to the non-pregnant women).
To our knowledge, this is the first study to characterize
the circulating B cell compartment in pregnancy while
taking into account the maturational stages of the different
B cell subsets. Furthermore, the study was conducted pro-
spectively, from the 3rd trimester of pregnancy to post-
partum, in a sample of 43 pregnant women.
The pregnancy-associated B lymphopenia that we iden-
tified in our study has already been described in animal
models [32, 33] and in humans [17–27]. According to
Medina et al. [32], B lymphopoiesis in bone marrow is
selectively reduced during normal pregnancy because
of hormonal influences. Furthermore, Muzzio et al. [33]
demonstrated that B lymphopoiesis is reduced in late
pregnancy, when estradiol levels are high. Cellular migra-
tion is another mechanism that can contribute to B cell
lymphopenia. Studies of animal models have shown that
monocytes and other immune cells migrate to the uterus
during the later stages of pregnancy due to changes in the
expression of chemokines [34, 35]. Furthermore, small
populations of B cells have been identified in the decidua,
suggesting leucocyte recruitment into the maternal-fetal
interface [36]. The biological meaning of this suppression
of B lymphopoiesis in normal pregnancy is uncertain but
is probably related to the physiological immune tolerance.
In this study, we found that the absolute counts of the
majority of the B cell subsets were significantly lower in
the 3rd trimester of pregnancy than in the non-pregnant
women, suggesting pregnancy-associated B lymphopenia
(though most pregnant women still presented values
within normal ranges). The increased blood volemia ob-
served during pregnancy could in part explain these obser-
vations. In fact, pregnant presented also decreased absolute
lymphocyte counts, along with decreased absolute counts
of T and NK cells, compared to non-pregnant (data not
shown). Nonetheless, B cell percentages in pregnant also
seem to decrease during pregnancy, which does not hap-
pens with either T cells or NK cells.
Compared to the percentages of peripheral blood naïve
B cells in the non-pregnant women, we found higher
values during the 3rd trimester and on delivery day, but
no differences were observed in absolute counts. This
relative increase in naïve B cells may be a consequence
of decreased differentiation of B cells into memory cells
and/or plasmablasts. In fact, Muzzio et al. [33] reported
the expansion of naïve B cells in pregnant mice. The high
levels of progesterone present in late pregnancy may poten-
tially explain this, as high progesterone levels inhibit B cell
activation in mice [37]. Our results may also be explained
by the mobilization of more differentiated B subsets from
peripheral blood to other body tissues.
Normal pregnancy has been compared to a state of
quiescent systemic inflammation, while parturition has
been likened to an immunological reaction that results
in the recruitment of immune cells not only to the ma-
ternal-fetal interface but also to the systemic circulation
[38]. The results of our study support this idea, as we
identified higher counts and percentages of CD24hiCD38hi
Bregs post-partum relative to during the 3rd trimester
and on delivery day. This observation may represent a
regulatory mechanism for the suppression of immune
cell activation events and may also explain the increased
susceptibility to infections that occurs during the post-
partum period and the altered clinical outcomes of some
autoimmune diseases.
Interestingly, we found that while the majority of B
cell subsets increased to levels closer to those of the
non-pregnant (or to normal values) from the third tri-
mester of pregnancy to post-partum, the percentages of
CD24hiCD38hi Bregs were significantly higher in the
post-partum compared to the non-pregnant women. Be-
cause B lymphopoiesis is under endocrine regulation
during pregnancy [32, 33], our results may be explained
by the decline of hormonal levels that typically occurs
post-partum, which may have lead both to lymphopoi-
esis recovery and to B cell activation. As hypothesized
by Medina et al. [32], this result may be of clinical utility
to increase lymphocyte formation in transplanted pa-
tients and in those with immunodeficiencies.
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Unlike for the CD24hiCD38hi Bregs, no significant dif-
ferences between the non-pregnant and the pregnant or
from the 3rd trimester of pregnancy to post-partum
were identified for IL-10 Bregs (cell percentages) or for
CD24hiCD27+ Bregs (cell percentages and counts). This
heterogeneity of Breg subsets has been reported in other
studies with humans [39]. Furthermore, CD24hiCD27+
Bregs, an activated memory subset, are more mature
than transitional CD24hiCD38hi Bregs; thus, it is more
likely for them to develop into antibody-producing cells
that no longer possess a regulatory function [40].
The differences between pregnant and non-pregnant
women identified for age, and parity are not likely to
bias our results. In fact, among all of the women who
were included in our study, counts and percentages of B
cell subsets were not significantly associated with age, as
demonstrated by the non-significant Spearman correl-
ation coefficients between these variables (see Additional
file 1). Furthermore, in the vast majority of cases, there
were no statistically significant differences in counts and
percentages of B cell subsets among women, despite
parity (see Additional file 2). Finally, in the vast majority of
cases, we have also not found significant associations be-
tween counts (and percentages) of B cell subsets and gesta-
tional age at the 3rd trimester of pregnancy (see Additional
file 3), gestational age at delivery (see Additional file 4),
length of time post-partum until the collection of the final
blood samples (see Additional file 5), and time since last
pregnancy in the non-pregnant (see Additional file 6).
Previous studies have identified differences in the
counts and percentages of B cells (total and subsets) be-
tween neonates and individuals of up to 50 years of age
[41]. However, to the best of our knowledge, there are
no data regarding B cell variation in women over short
periods of time, such as that of our study.
Although the pregnant women received analgesia and/
or anesthesia, which may cause temporary changes in
maternal blood pressure, this is unlikely to cause import-
ant changes in B cell counts because regional administra-
tion is generally associated with low plasma levels of these
drugs. Ideally, samples collected before pregnancy would
have been compared with samples collected during preg-
nancy in the same individuals; however, this would have
been very difficult for us from a practical point of view.
The fact that several of the changes that were observed
during the 3rd trimester of pregnancy seem to be reversed
during the post-partum period suggests that comparisons
with non-pregnant women were adequate.
In future research, it is important to investigate whether
B cell subset characterization could help to identify risk
markers for the development of obstetric complications in
pregnant women with or without autoimmune diseases. In
this context, it would also be important to clarify the
role of B-cell activating factor (BAFF), an essential survival
factor for transitional B cells, and of CD23, a B-lymphocyte
differentiation marker.
Conclusion
According to our study, the characteristics of peripheral
B cell compartment differ significantly between pregnant
and non-pregnant women and vary over time from late
pregnancy to post-partum. Such findings may allow us to
recognize normal fluctuations in B cell subsets to better
understand immune regulation during human pregnancy
and to identify new strategies for the diagnosis and treat-
ment of pregnancy-associated disturbances as well as
the mechanisms of maternal responses to vaccination and
infection.
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